SCHEMBL217194

SCHEMBL217194

ClC(Cl)(Cl)c1nc(-c2ccc3ccccc3c2)nc(C(Cl)(Cl)Cl)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
CYP1A2 P05177 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP11B1 P15538 3/20 0.41
CYP11B2 P19099 3/20 0.41
CYP17A1 P05093 1/20 0.41
CYP19A1 P11511 1/20 0.41
ALOX5 P09917 1/20 0.40
HSD17B1 P14061 1/20 0.39
HSD17B2 P37059 1/20 0.39
CYP2C9 P11712 2/20 0.39
HPGD P15428 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29389195 1.00 GSTP1 (0.41) GSTP1ESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL9372711 0.83 SMN1; SMN2 (0.58) CYP1A2SMN1; SMN2ALDH1A1KDM4EHSD17B10
SCHEMBL4413811 0.83 KDM4E (0.39) GSTP1ESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL25817350 0.81 GSTP1 (0.41) GSTP1ESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL21048184 0.80 CYP1A1 (0.40) CYP1A2ALDH1A1KDM4EHSD17B10MEN1
SCHEMBL29860227 0.80 HSD17B1 (0.50) GSTP1CYP1A2CYP11B1CYP11B2CYP17A1
SCHEMBL482246 0.80 HSD17B1 (0.50) GSTP1CYP1A2CYP11B1CYP11B2CYP17A1
SCHEMBL8412982 0.80 NPC1 (0.38) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL16928118 0.79 HRH4 (0.50) CYP1A2SMN1; SMN2CYP2C19
SCHEMBL125466 0.79 MEN1 (0.44) CYP1A2SMN1; SMN2ALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289967-B1 TRIAZINE-BASED COMPOUND COMPRISING FUNCTIONALIZED ALKYLTHIO GROUPS, AND PHOTOPOLYMERIZATION INITIATOR LG CHEMICAL LTD (KR) 2009-10-28 EP claimed
US-20040253547-A1 Pattern formation method MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. 2004-12-16 US claimed
US-6797739-B1 Triazene-based compound comprising functionalized alkylthio groups, and photopolymerization initiator LG CHEMICAL CO., LTD. (KR) 2004-09-28 US claimed
EP-1289967-A1 TRIAZINE-BASED COMPOUND COMPRISING FUNCTIONALIZED ALKYLTHIO GROUPS, AND PHOTOPOLYMERIZATION INITIATOR LG Chemical Co. Ltd (KR) 2003-03-12 EP claimed
WO-2001096317-A1 TRIAZINE-BASED COMPOUND COMPRISING FUNCTIONALIZED ALKYLTHIO GROUPS, AND PHOTOPOLYMERIZATION INITIATOR LG CHEMICAL CO., LTD (KR) 2001-12-20 WO claimed
US-20260146026-A1 COMPOUND, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING ELECTRONIC COMPONENT ADEKA CORPORATION (JP) 2026-05-28 US disclosed
EP-4610254-A1 COMPOUND, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING ELECTRONIC COMPONENT ADEKA CORPORATION (JP) 2025-09-03 EP disclosed
WO-2025018116-A1 COMPOUND, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND POLYMER 株式会社ADEKA 2025-01-23 WO disclosed
US-20240352203-A1 FILM-FORMING MATERIAL FOR SEMICONDUCTOR, MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, PROCESS MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, UNDERLAYER FILM-FORMING MATERIAL, UNDERLAYER FILM, AND SEMICONDUCTOR DEVICE ADEKA CORPORATION (JP) 2024-10-24 US disclosed
EP-3597670-B1 WATER-SOLUBLE COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT THEREOF, AND CURED PRODUCT THEREOF, AND ACYL PHOSPHINATE ADEKA CORP (JP) 2024-07-10 EP disclosed
EP-4375750-A1 FILM-FORMING MATERIAL FOR SEMICONDUCTOR, MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, PROCESS MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, UNDERLAYER FILM-FORMING MATERIAL, UNDERLAYER FILM, AND SEMICONDUCTOR DEVICE ADEKA CORPORATION (JP) 2024-05-29 EP disclosed
WO-2024090369-A1 COMPOUND, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING ELECTRONIC COMPONENT 株式会社ADEKA 2024-05-02 WO disclosed
EP-0618933-A1 PRESSURE-SENSITIVE ADHESIVE. MINNESOTA MINING & MFG (US) 1994-10-12 EP disclosed
US-5284735-A Mixture of radical-polymerizable compound having two or more double bonds, photoinitiator, high molecular weight organic compound and di-substituted ethylene compound OKAMOTO CHEMICAL INDUSTRY CO., LTD. (JP) 1994-02-08 US disclosed
WO-1993013149-A1 PRESSURE-SENSITIVE ADHESIVE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-07-08 WO disclosed
US-5202361-A Radiation curable; blend of acrylate esters, unsaturated monomers, a-olefin polymers and photoinitiator MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-04-13 US disclosed
US-5198325-A PHOTOPOLYMERIZABLE MIXTURE, COPYING MATERIAL CONTAINING SAME AND PROCESS FOR PRODUCING HIGHLY HEAT-RESISTANT RELIEF STRUCTURES WHEREIN A TRIHALOMETHYL IS THE PHOTOINITIATOR HOECHST AKTIENGESELLSCHAFT (DE) 1993-03-30 US disclosed
EP-0505094-A1 Speed stabilised positive-acting photoresist compositions MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-09-23 EP disclosed
EP-0292868-A2 Light sensitive composition, registration material containing it and process for the fabrication of heat resistant relief structures HOECHST AKTIENGESELLSCHAFT (DE) 1988-11-30 EP disclosed
US-4189323-A Radiation-sensitive copying composition HOECHST AKTIENGESELLSCHAFT (DE) 1980-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260146026-A1 COMPOUND, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING ELECTRONIC COMPONENT CBR3, CBR1, NOTUM GSTP1 1379/4885ESR1 1240/4885ESR2 432/4885
US-20240352203-A1 FILM-FORMING MATERIAL FOR SEMICONDUCTOR, MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, PROCESS MEMBER-FORMING MATERIAL FOR SEMICONDUCTOR, UNDERLAYER FILM-FORMING MATERIAL, UNDERLAYER FILM, AND SEMICONDUCTOR DEVICE FBXL19, SRSF9, CNOT9 GSTP1 3412/4885ESR1 468/4885ESR2 1745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.